Compile Data Set for Download or QSAR
Report error Found 95 Enz. Inhib. hit(s) with Target = 'Epidermal growth factor receptor [1-18,20-1210,T790M]'
LigandPNGBDBM701471(US20240352000, Example 17)
In DepthDetails

LigandPNGBDBM701455(US20240352000, Example 1)
In DepthDetails

LigandPNGBDBM701456(US20240352000, Example 2)
In DepthDetails

LigandPNGBDBM701457(US20240352000, Example 3)
In DepthDetails

LigandPNGBDBM701458(US20240352000, Example 4)
In DepthDetails

LigandPNGBDBM701459(US20240352000, Example 5)
In DepthDetails

LigandPNGBDBM701460(US20240352000, Example 6)
In DepthDetails

LigandPNGBDBM701461(US20240352000, Example 7)
In DepthDetails

LigandPNGBDBM701462(US20240352000, Example 8)
In DepthDetails

LigandPNGBDBM701463(US20240352000, Example 9)
In DepthDetails

LigandPNGBDBM701466(US20240352000, Example 12)
In DepthDetails

LigandPNGBDBM701467(US20240352000, Example 13)
In DepthDetails

LigandPNGBDBM625594(US20230322822, Compound 6)
Affinity DataIC50: 1.10nMAssay Description:To assess the effect of compounds on the activity of wild-type and mutant EGFR kinases, kinase activity was tested by measuring ATP consumption in an...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM50029668(AZD-9291 | Osimertinib | US10085983, Compound AZD-...)
Affinity DataIC50: 1.60nMAssay Description: This assay quantifies the phosphorylation of EGFR at Tyr1068 and was used to measure the inhibitory effect of compounds on the transgenic EGFR del19...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022090481

LigandPNGBDBM625593(US20230322822, Compound 5)
Affinity DataIC50: 1.90nMAssay Description:To assess the effect of compounds on the activity of wild-type and mutant EGFR kinases, kinase activity was tested by measuring ATP consumption in an...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM701465(US20240352000, Example 11)
In DepthDetails

LigandPNGBDBM625598(US20230322822, Compound 14)
Affinity DataIC50: 2.30nMAssay Description:To assess the effect of compounds on the activity of wild-type and mutant EGFR kinases, kinase activity was tested by measuring ATP consumption in an...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM538135(US11253516, Example 37)
Affinity DataIC50: 2.70nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM538109(US11253516, Example 11)
Affinity DataIC50: 3.10nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM547941(WO2022090481, Example I-162)
Affinity DataIC50: 3.20nMAssay Description: This assay quantifies the phosphorylation of EGFR at Tyr1068 and was used to measure the inhibitory effect of compounds on the transgenic EGFR del19...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022090481

LigandPNGBDBM625596(US20230322822, Compound 11)
Affinity DataIC50: 3.40nMAssay Description:To assess the effect of compounds on the activity of wild-type and mutant EGFR kinases, kinase activity was tested by measuring ATP consumption in an...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM625598(US20230322822, Compound 14)
Affinity DataIC50: 3.60nMAssay Description:To assess the effect of compounds on the activity of wild-type and mutant EGFR kinases, kinase activity was tested by measuring ATP consumption in an...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM625600(US20230322822, Compound 32)
Affinity DataIC50: 3.80nMAssay Description:To assess the effect of compounds on the activity of wild-type and mutant EGFR kinases, kinase activity was tested by measuring ATP consumption in an...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM625592(US20230322822, Compound 2)
Affinity DataIC50: 3.90nMAssay Description:To assess the effect of compounds on the activity of wild-type and mutant EGFR kinases, kinase activity was tested by measuring ATP consumption in an...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM538108(US11253516, Example 10)
Affinity DataIC50: 4nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM538127(US11253516, Example 29)
Affinity DataIC50: 4nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM50160870(CHEMBL3787344 | WO2022090481, Example nazartinib |...)
Affinity DataIC50: 4.10nMAssay Description: This assay quantifies the phosphorylation of EGFR at Tyr1068 and was used to measure the inhibitory effect of compounds on the transgenic EGFR del19...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022090481

LigandPNGBDBM625591(US20230322822, Compound 1)
Affinity DataIC50: 4.10nMAssay Description:To assess the effect of compounds on the activity of wild-type and mutant EGFR kinases, kinase activity was tested by measuring ATP consumption in an...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM538101(US11253516, Example 3)
Affinity DataIC50: 5nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM547965(WO2022090481, Example I-186)
Affinity DataIC50: 5.20nMAssay Description: This assay quantifies the phosphorylation of EGFR at Tyr1068 and was used to measure the inhibitory effect of compounds on the transgenic EGFR del19...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022090481

LigandPNGBDBM547888(WO2022090481, Example I-107)
Affinity DataIC50: 6.06nMAssay Description: This assay quantifies the phosphorylation of EGFR at Tyr1068 and was used to measure the inhibitory effect of compounds on the transgenic EGFR del19...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022090481

LigandPNGBDBM625592(US20230322822, Compound 2)
Affinity DataIC50: 6.5nMAssay Description:To assess the effect of compounds on the activity of wild-type and mutant EGFR kinases, kinase activity was tested by measuring ATP consumption in an...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM625597(US20230322822, Compound 12)
Affinity DataIC50: 6.90nMAssay Description:To assess the effect of compounds on the activity of wild-type and mutant EGFR kinases, kinase activity was tested by measuring ATP consumption in an...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM547807(WO2022090481, Example I-064 | WO2022090481, Exampl...)
Affinity DataIC50: 7.80nMAssay Description: This assay quantifies the phosphorylation of EGFR at Tyr1068 and was used to measure the inhibitory effect of compounds on the transgenic EGFR del19...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022090481

LigandPNGBDBM625597(US20230322822, Compound 12)
Affinity DataIC50: 8.10nMAssay Description:To assess the effect of compounds on the activity of wild-type and mutant EGFR kinases, kinase activity was tested by measuring ATP consumption in an...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM547983(WO2022090481, Example I-204)
Affinity DataIC50: 8.30nMAssay Description: This assay quantifies the phosphorylation of EGFR at Tyr1068 and was used to measure the inhibitory effect of compounds on the transgenic EGFR del19...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022090481

LigandPNGBDBM538133(US11253516, Example 35)
Affinity DataIC50: 8.30nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM625600(US20230322822, Compound 32)
Affinity DataIC50: 8.90nMAssay Description:To assess the effect of compounds on the activity of wild-type and mutant EGFR kinases, kinase activity was tested by measuring ATP consumption in an...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM547940(WO2022090481, Example I-161)
Affinity DataIC50: 9.30nMAssay Description: This assay quantifies the phosphorylation of EGFR at Tyr1068 and was used to measure the inhibitory effect of compounds on the transgenic EGFR del19...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022090481

LigandPNGBDBM538104(US11253516, Example 6)
Affinity DataIC50: 10nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM625594(US20230322822, Compound 6)
Affinity DataIC50: 10.5nMAssay Description:To assess the effect of compounds on the activity of wild-type and mutant EGFR kinases, kinase activity was tested by measuring ATP consumption in an...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM625595(US20230322822, Compound 9)
Affinity DataIC50: 11nMAssay Description:To assess the effect of compounds on the activity of wild-type and mutant EGFR kinases, kinase activity was tested by measuring ATP consumption in an...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM538100(US11253516, Example 2)
Affinity DataIC50: 12nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM538103(US11253516, Example 5)
Affinity DataIC50: 13nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM538119(US11253516, Example 21)
Affinity DataIC50: 14nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM625591(US20230322822, Compound 1)
Affinity DataIC50: 14.6nMAssay Description:To assess the effect of compounds on the activity of wild-type and mutant EGFR kinases, kinase activity was tested by measuring ATP consumption in an...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM537979(US11248003, Example TRE-069)
Affinity DataIC50: 16nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM625596(US20230322822, Compound 11)
Affinity DataIC50: 17.3nMAssay Description:To assess the effect of compounds on the activity of wild-type and mutant EGFR kinases, kinase activity was tested by measuring ATP consumption in an...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM538123(US11253516, Example 25)
Affinity DataIC50: 18nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

LigandPNGBDBM538125(US11253516, Example 27)
Affinity DataIC50: 21nMAssay Description:The composition of the assay buffer used in the activity measurement was 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 7.5 mM MgCl2, 3 mM KCl, 0.01% Tween 20, ...More data for this Ligand-Target Pair
In DepthDetails
US Patent

Displayed 1 to 50 (of 95 total ) | Next | Last >>
Jump to: